Welcome to Novo Nordisk Science Hub

Are you a healthcare professional?

OW 2026 15 November 2026

Real-World Clinical Outcomes with Semaglutide in a Population with Overweight or Class I Obesity

Sorry! It looks like the page you are trying to access contains materials that are still under embargo. Please come back and check again later.
Keywords
Obesity
Congress poster
GLP-1 RA
Semaglutide
RWE